FI933531L - Imidazopyridin paf/h1 antagonister - Google Patents

Imidazopyridin paf/h1 antagonister Download PDF

Info

Publication number
FI933531L
FI933531L FI933531A FI933531A FI933531L FI 933531 L FI933531 L FI 933531L FI 933531 A FI933531 A FI 933531A FI 933531 A FI933531 A FI 933531A FI 933531 L FI933531 L FI 933531L
Authority
FI
Finland
Prior art keywords
imidazopyride
paf
antagonist
imidazopyride paf
Prior art date
Application number
FI933531A
Other languages
English (en)
Finnish (fi)
Other versions
FI933531A7 (fi
FI933531A0 (fi
Inventor
David Alker
Robert John Bass
Kelvin Cooper
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI933531A7 publication Critical patent/FI933531A7/fi
Publication of FI933531A0 publication Critical patent/FI933531A0/fi
Publication of FI933531L publication Critical patent/FI933531L/fi
Priority to FI973558A priority Critical patent/FI101225B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Prostheses (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)
FI933531A 1991-02-13 1992-01-24 Imidazopyridin paf/h1 antagonister FI933531L (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI973558A FI101225B (fi) 1991-02-13 1997-08-29 Menetelmä terapeuttisesti käyttökelpoisten 2-metyyli-imidatso£4,5-c|py rid-1-yylijohdannaisten valmistamiseksi

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919102997A GB9102997D0 (en) 1991-02-13 1991-02-13 Therapeutic agents
PCT/EP1992/000163 WO1992014734A1 (en) 1991-02-13 1992-01-24 Imidazopyridine paf/h1 antagonists

Publications (3)

Publication Number Publication Date
FI933531A7 FI933531A7 (fi) 1993-08-10
FI933531A0 FI933531A0 (fi) 1993-08-10
FI933531L true FI933531L (fi) 1993-08-10

Family

ID=10689943

Family Applications (1)

Application Number Title Priority Date Filing Date
FI933531A FI933531L (fi) 1991-02-13 1992-01-24 Imidazopyridin paf/h1 antagonister

Country Status (29)

Country Link
US (1) US5358953A (enExample)
EP (1) EP0572425B1 (enExample)
JP (1) JP2506541B2 (enExample)
KR (1) KR970005302B1 (enExample)
CN (1) CN1040326C (enExample)
AT (1) ATE109482T1 (enExample)
AU (1) AU650322B2 (enExample)
BR (1) BR9205615A (enExample)
CA (1) CA2099381C (enExample)
CZ (1) CZ280504B6 (enExample)
DE (1) DE69200304T2 (enExample)
DK (1) DK0572425T3 (enExample)
EG (1) EG20085A (enExample)
ES (1) ES2059212T3 (enExample)
FI (1) FI933531L (enExample)
GB (1) GB9102997D0 (enExample)
HU (2) HUT65947A (enExample)
IE (1) IE65125B1 (enExample)
IL (1) IL100887A (enExample)
MX (1) MX9200589A (enExample)
MY (1) MY108437A (enExample)
NO (1) NO300592B1 (enExample)
NZ (1) NZ241597A (enExample)
PL (1) PL169304B1 (enExample)
RU (1) RU2114845C1 (enExample)
TW (1) TW227000B (enExample)
WO (1) WO1992014734A1 (enExample)
YU (1) YU48238B (enExample)
ZA (1) ZA921005B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2042421B1 (es) * 1992-05-22 1994-08-01 Uriach & Cia Sa J Procedimiento para la obtencion de la 8-cloro-11-*1-*(5-metil-3-piridil)metil*-4-piperidiliden*-6,11-dihidro-5h-benzo*5,6*ciclohepta*1,2-b*piridina.
EP0775139A1 (en) * 1994-08-10 1997-05-28 British Biotech Pharmaceuticals Limited Imidazopyridine derivatives as dual histamine (h1) and platelet activating factor (paf) antagonists
ES2087038B1 (es) * 1994-11-07 1997-03-16 Uriach & Cia Sa J Nuevas piperidinas con actividad antagonista del paf.
US5567711A (en) * 1995-04-19 1996-10-22 Abbott Laboratories Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists
GB9508748D0 (en) * 1995-04-28 1995-06-14 British Biotech Pharm Benzimidazole derivatives
AU698487B2 (en) * 1995-08-05 1998-10-29 British Biotech Pharmaceuticals Limited Imidazopyridine derivatives
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
DK1311269T3 (da) 2000-08-04 2012-03-26 Dmi Biosciences Inc Fremgangsmåde til anvendelse af diketopiperaziner og sammensætning, som indeholder dem
ES2572975T3 (es) 2003-05-15 2016-06-03 Ampio Pharmaceuticals, Inc. Tratamiento de enfermedades mediadas por los linfocitos T
US7687515B2 (en) * 2006-01-17 2010-03-30 N.V. Organon 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives
CN101932575B (zh) 2008-01-30 2013-06-12 日本脏器制药株式会社 哌啶衍生物
JP5856843B2 (ja) 2008-05-27 2016-02-10 アンピオ ファーマシューティカルズ，インコーポレイテッド ジケトピペラジンを用いた医薬組成物
JP5978296B2 (ja) * 2011-06-28 2016-08-24 フジアン・ミンドン・レジュヴネイション・ファーマスーティカル・カンパニー・リミテッド 抗アレルギ性ベンゾシクロヘプタチオフェン誘導体
US9925300B2 (en) 2011-10-10 2018-03-27 Ampio Pharmaceuticals, Inc. Implantable medical devices with increased immune tolerance, and methods for making and implanting
PH12014500685B1 (en) 2011-10-10 2018-10-03 Ampio Pharmaceuticals Inc Treatment of degenerative joint disease
JP6231484B2 (ja) * 2011-10-28 2017-11-15 アンピオ ファーマシューティカルズ，インコーポレイテッド 鼻炎の処置
CN105101965B (zh) 2013-03-15 2021-03-09 安皮奥制药股份有限公司 用于干细胞活动化、归巢、扩增和分化的组合物及其使用方法
JP6723222B2 (ja) 2014-08-18 2020-07-15 アンピオ ファーマシューティカルズ，インコーポレイテッド 関節病態の治療
US11389512B2 (en) 2015-06-22 2022-07-19 Ampio Pharmaceuticals, Inc. Use of low molecular weight fractions of human serum albumin in treating diseases
CN113880801A (zh) * 2020-07-03 2022-01-04 合肥医工医药股份有限公司 一类三环化合物、其制备方法及其医药用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL132137C (enExample) * 1963-04-24
JPH03503889A (ja) * 1988-03-15 1991-08-29 ジー．ディー．サール　アンド　カンパニー ＰＡＦ拮抗剤としての１Ｈ／３Ｈ‐［４‐（Ｎ，Ｎ‐ジシクロアルキル／分枝アルキルカルボキサミド）‐ベンジル］イミダゾ［４，５‐ｃ］ピリジン類
JP2511550B2 (ja) * 1988-04-28 1996-06-26 シェリング・コーポレーション 融合多環式化合物、組成物、製造方法およびｐａｆ拮抗、抗ヒスタミンおよび／または抗炎症剤としてのその使用
US5250681A (en) * 1988-06-02 1993-10-05 Ajinomoto Co., Inc. Piperidine derivatives and hypotensives containing the same
US5114919A (en) * 1990-02-26 1992-05-19 Merck & Co., Inc. Adjuncts in cancer chemotherapy
AU642265B2 (en) * 1990-05-09 1993-10-14 Pfizer Inc. Imidazo (4,5-c) pyridines with PAF antagonist activity

Also Published As

Publication number Publication date
AU650322B2 (en) 1994-06-16
ATE109482T1 (de) 1994-08-15
AU1168392A (en) 1992-09-15
BR9205615A (pt) 1994-05-17
YU48238B (sh) 1997-08-22
DE69200304T2 (de) 1994-12-08
CZ280504B6 (cs) 1996-02-14
FI933531A7 (fi) 1993-08-10
PL169304B1 (pl) 1996-06-28
FI933531A0 (fi) 1993-08-10
CS42592A3 (en) 1992-09-16
US5358953A (en) 1994-10-25
ZA921005B (en) 1993-08-12
HU9302327D0 (en) 1993-10-28
DE69200304D1 (de) 1994-09-08
HU211202A9 (en) 1995-11-28
CA2099381A1 (en) 1992-08-14
ES2059212T3 (es) 1994-11-01
NZ241597A (en) 1993-04-28
MY108437A (en) 1996-09-30
IL100887A (en) 1996-01-19
IE920449A1 (en) 1992-08-12
JP2506541B2 (ja) 1996-06-12
IE65125B1 (en) 1995-10-04
CN1040326C (zh) 1998-10-21
YU14392A (sh) 1994-11-15
EG20085A (en) 1997-05-31
GB9102997D0 (en) 1991-03-27
NO300592B1 (no) 1997-06-23
IL100887A0 (en) 1992-11-15
TW227000B (enExample) 1994-07-21
EP0572425B1 (en) 1994-08-03
EP0572425A1 (en) 1993-12-08
HUT65947A (en) 1994-08-29
MX9200589A (es) 1992-10-01
NO932889D0 (no) 1993-08-13
WO1992014734A1 (en) 1992-09-03
KR970005302B1 (ko) 1997-04-15
DK0572425T3 (da) 1994-09-12
CN1064275A (zh) 1992-09-09
JPH06504992A (ja) 1994-06-09
RU2114845C1 (ru) 1998-07-10
NO932889L (no) 1993-08-13
CA2099381C (en) 1996-07-09

Similar Documents

Publication Publication Date Title
FI935880A7 (fi) Immobiliserade lewis-syrakatalysatorer
FI935134A7 (fi) Substituoidut 3-aminokinuklidiinit
FI925100A7 (fi) Substituoituja bifenyylipyridoneja
FI933531L (fi) Imidazopyridin paf/h1 antagonister
FI910116L (fi) sigma-delta-modulator foer d/a-omvandlare
FI925054L (fi) Imidazopyridin paf-antagonister
FI914300A0 (fi) Höyrylaatikko
FI923200A7 (fi) Coccidiosisvacciner
FI933062L (fi) Vedklyv
FI935280L (fi) Dihydroxiindanontyrosinkinasinhibitorer
FI922681L (fi) Nytt foerpacknings/behaollarsystem
ATA68191A (de) Schubkastenauszug
DE69232141D1 (de) Sender-Empfänger
FI934447A0 (fi) Nytt immunhaemmande aemne fraon strptomyces braegensis
FI922683L (fi) Nytt foerpacknings/behaollarsystem
DK172391D0 (da) Musefaelde
NO305649B1 (no) Silot°mmeanordning
TR25953A (tr) SüBSTITüE EDILMIS 2-ARILPIROLLER
ATE163916T1 (de) Ethyl-6-formyloxy-4-hexenoat
FI920668A7 (fi) Oksatsinobentsatsoliyhdisteet
FI922682L (fi) Nytt foerpacknings/behaollarsystem
FI910541A0 (fi) Liukueste
NZ241872A (en) Substituted oxaspirononane paf antagonists
FI940890A7 (fi) Uusia yhdisteitä
TR26694A (tr) SüBSTITüE EDILMIS 4-HETARIL-PIRAZOLINLER

Legal Events

Date Code Title Description
FC Application refused